Accolade, Inc. ACCD
Set alert
7.02 0.00 0.00%
At close · Apr 8
7.02 Day range 7.02
52-week range unavailable
- YTD
- +105.26%
- 1 year
- -23.61%
- Open
- 7.02
- Prev close
- 7.02
- Mkt cap
- 575.59M
- Vol
- 4.54M
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 7.02
- High
- 7.02
- Forward P/E
- -4.05
- Beta
- 2.02
- Short ratio
- 2.59
- Inst. own
- 83.49%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Jan 9, 2025
- 50-d avg
- 3.51
- 200-d avg
- 5.37
- 1y target
- 7.17
Analyst view
Consensus: buy
Buy
Price target (mean) 7.17 +2.2% upside
Now 7.02
- Target (low)
- 5.00
- Target (mean)
- 7.17
- Target (high)
- 9.50
Ratings (0m) 14 11 buy · 3 hold · 0 sell
- Strong buy3
- Buy8
- Hold3
- Sell0
- Strong sell0
Recommendation trend
- This month 14
- 1 month ago 14
- 2 months ago 15
- 3 months ago 17
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.16 | -0.17 – -0.15 | -0.0705 | -127.0% | 106.00M | +6.7% | 6 |
| Next quarter | 0.21 | 0.18 – 0.24 | 0.0978 | +114.7% | 142.39M | +14.1% | 6 |
| Current year | -0.25833 | -0.28 – -0.23 | -0.5074 | +49.1% | 465.60M | +12.4% | 6 |
| Next year | -0.118 | -0.31 – -0.03 | -0.25833 | +54.3% | 524.87M | +12.7% | 5 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 17, 2024 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Oct 11, 2024 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Oct 9, 2024 | Truist Securities | Maintained | Buy | Buy |
| Oct 9, 2024 | Canaccord Genuity | Maintained | Buy | Buy |
| Oct 9, 2024 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Oct 9, 2024 | Stephens & Co. | Maintained | Overweight | Overweight |
| Oct 8, 2024 | Needham | Reiterated | Buy | Buy |
| Oct 7, 2024 | Needham | Reiterated | Buy | Buy |
| Jun 28, 2024 | Guggenheim | Maintained | Buy | Buy |
| Jun 28, 2024 | Stifel | Maintained | Buy | Buy |
| Jun 28, 2024 | Truist Securities | Maintained | Buy | Buy |
| Jun 28, 2024 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Jun 28, 2024 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Jun 28, 2024 | Canaccord Genuity | Maintained | Buy | Buy |
| Jun 28, 2024 | Needham | Maintained | Buy | Buy |
| Jun 24, 2024 | Needham | Reiterated | Buy | Buy |
| May 8, 2024 | Guggenheim | Maintained | Buy | Buy |
| Apr 30, 2024 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Apr 26, 2024 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Apr 26, 2024 | Truist Securities | Maintained | Buy | Buy |
| Apr 26, 2024 | Canaccord Genuity | Maintained | Buy | Buy |
| Apr 26, 2024 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Apr 26, 2024 | Needham | Maintained | Buy | Buy |
| Apr 22, 2024 | Stifel | Maintained | Buy | Buy |
| Feb 26, 2024 | Leerink Partners | Initiated | — | Outperform |
| Jan 19, 2024 | Needham | Reiterated | Buy | Buy |
| Jan 9, 2024 | Truist Securities | Maintained | Buy | Buy |
| Jan 9, 2024 | Piper Sandler | Maintained | Overweight | Overweight |
| Jan 9, 2024 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Jan 9, 2024 | Raymond James | Maintained | Outperform | Outperform |